From Dr Eliot Forster, Executive Chair of MedCity
Another productive month for MedCity, with successful launches of Angels in MedCity and the OneStart competition, productive work to bring together academia, industry and local government to focus on dementia, and some exciting and high profile science highlighting the excellence of our universities. More details are below, and we are grateful for any help you can provide in highlighting these new opportunities to investors, early-stage companies and aspiring entrepreneurs in your networks.
Closer to home, I am delighted to share the good news that MedCity now has a Chief Operating Officer in the form of Sarah Haywood. Some of you will already know Sarah since she has been critical to the establishment and early success of MedCity in her former role as Head of Life Sciences at London & Partners. Her energy, knowledge and creativity will be a huge asset as we motor ahead.
More good news comes in the form of new Advisory Board member Jo Pisani, Partner, Global Pharmaceuticals and Life Sciences, at PricewaterhouseCoopers, who brings a great depth of industry experience and expertise to the group.